Back to trial detailsIntake questionnaire
AMT-260 Gene Therapy Study in Adults With Unilateral Refractory Mesial Temporal Lobe Epilepsy
Applying to Massachusetts General Hospital · Boston, Massachusetts
Answer a few short questions to share with the research team.
0 of 3 answered